View Past PerformanceNuheara バランスシートの健全性財務の健全性 基準チェック /06Nuhearaの健全性を判断するにはデータが不十分です主要情報n/a負債資本比率n/a負債インタレスト・カバレッジ・レシオn/a現金n/aエクイティn/a負債合計n/a総資産n/a財務の健全性に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • Apr 10Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 1.850332 million.Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 1.850332 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 30,838,873 Price\Range: AUD 0.06 Security Features: Attached Options Transaction Features: Subsequent Direct Listingお知らせ • Nov 22Nuheara Limited Announces the Retirement of David Cannington as Non-Executive DirectorNuheara Limited announced that Non-executive Director and co-founder Mr. David Cannington has announced his decision to retire from the Nuheara Board of Directors. As a co-founder of the company and having previously stepped down from executive duties in March 2022, David now concludes his service on the Board.お知らせ • Nov 09Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 3.929624 million.Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 3.929624 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 3,846,154 Price\Range: AUD 0.13 Discount Per Security: AUD 0.0039 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 19,458,649 Price\Range: AUD 0.13 Discount Per Security: AUD 0.0039 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 6,923,077 Price\Range: AUD 0.13 Discount Per Security: AUD 0.0039 Transaction Features: Rights Offeringお知らせ • Sep 15Nuheara Limited, Annual General Meeting, Nov 22, 2023Nuheara Limited, Annual General Meeting, Nov 22, 2023, at 09:00 W. Australia Standard Time. Location: Anzac Club, 28 St Georges Terrace, Perth WA Australiaお知らせ • Jul 18Nuheara Limited Announces Appointment of Catherine Morgan as Head of Compliance, Regulatory and LegalNuheara Limited announced the key Executive appointment of Catherine Morgan as the Head of Compliance, Regulatory and Legal. This appointment completes Nuheara's global restructure announced 28 April 2023 and cements the Company's transformation over the past two years into a medical device manufacturer of world-first US FDA- cleared Over The Counter (OTC) Hearing Aids. Catherine joins the Nuheara C-suite with over +20 years of experience in the hearing industry, bringing a deep understanding of the hearing healthcare, medical device industry, global regulatory requirements, and quality standards. In this new role Catherine will be responsible for driving regulatory strategies, ensuring adherence to global regulations and standards, and driving continuous improvement initiatives within quality management systems. They will collaborate closely with cross-functional teams to streamline regulatory submissions, enhance product quality, and foster a culture of continuous improvement in all aspects of regulatory and quality operations. Prior to joining Nuheara, Catherine held senior leadership positions at the National Acoustic Laboratories and more than 14 years with Cochlear Ltd. Catherine has a proven track record of successfully navigating complex regulatory landscapes and implementing strong clinical quality management processes and while fostering a culture of regulatory compliance and quality excellence within the hearing market.お知らせ • Jun 07Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 4.4 million.Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 4.4 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 24,275,862 Price\Range: AUD 0.145 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 6,068,966 Price\Range: AUD 0.145 Transaction Features: Subsequent Direct Listingお知らせ • Jan 04Nuheara Announces Commercial Availability of HP Hearing PRO OTC Hearing AidNuheara announced the commercial availability of its HP Hearing PRO. Consumers can now pre-order the HP Hearing PRO self-fitting, air-conduction, OTC hearing soon be able to purchase the product from any retailer carrying the product including Best Buy and Crutchfield. Nuheara's HP Hearing PRO is the first product cleared through the FDA's 510(k) process for both 874.3325 self-fitting and the 800.30 OTC hearing aid classifications under a new product classification code "QUH". HP Hearing PRO is the first FDA cleared self-fitting OTC hearing aid with Hybrid Active Noise Cancellation. The innovative Ear ID(TM) software-in-medical-device and earbud form factor sets the HP Hearing PRO apart from other devices on the market . The HP Hearing PRO self-fitting OTC hearing aids look nothing like a traditional hearing aid. The HP Hearing PRO self- fitting OTC hearing aid brings together superb medical-grade hearing aid technology with the highly desired features of wireless earbuds into a multifunctional device. Users can enjoy clinically-proven natural sound quality. The HP Hearing PRO provides a lifestyle-friendly hearing aid experience with support for situational use and clinically-proven 30% improved hearing using the Focus directionality feature, adjusted to the user's preferences with a tap of the HP Hearing app. Orders can now be placed from retailers and ecommerce partners throughout the US. The recommended retail price for a pair of HP Hearing PRO hearing aids along with an on-the-go charging case is USD 699.00. Product is expected to ship to customers before the end of calendar Quarter 1, 2023. Built to medical-device standards and meeting all FDA requirements for safety and efficacy, the HP Hearing PRO features Ear ID(TM) self-fitting software and technology powered by Nuheara. The HP Hearing PRO self-fitting OTC hearing aid has been clinically proven to be substantially equivalent to a professionally fit hearing aid. The proprietary Ear ID software tests the wearer's individual hearing thresholds from low frequency to high frequency in each ear, then automatically programs the HP Hearing PRO hearing aids for each ear. This ability for the consumer to self-fit through the HP Hearing application, for iOS and Android platform mobile devices, allows a quick and easy acclimation experience for the consumer. The entire experience takes about 10-15 minutes from unboxing through customization of the user's personalized profile to accommodate their perceived mild-to-moderate hearing loss. In addition to the HP Hearing PRO's capabilities as an OTC hearing aid, this innovative product streams media and phone calls via Bluetooth(R). The Active Noise Cancellation minimizes background noise for an immersive sound experience during phone calls or when streaming music. Additional features include: Hearing app for iOS and Android; Rechargeable built-in Li-ion batteries; Medical-grade USB-C charge case; Battery life is up to 8 hours hearing aid processing per full charge per hearing aid; Clinically-proven natural sound quality. Most importantly, the HP Hearing PRO has been clinically validated through research cometed by the National Acoustic c Laboratories to provide a 30% speech understanding improvement in the presence of noise using the directional microphone feature called Focus. This is a huge benefit for consumers in restaurants or social situations where background noise makes understanding speech difficult. Now, at the touch of the HP Hearing app, a wearer can switch the directional microphone settings to Focus on sounds towards their front, quickly allowing for immediate improvement in speech understanding.財務状況分析短期負債: NUHR.Fの 短期資産 が 短期負債 をカバーしているかどうかを判断するにはデータが不十分です。長期負債: NUHR.Fの短期資産が 長期負債 をカバーしているかどうかを判断するにはデータが不十分です。デット・ツー・エクイティの歴史と分析負債レベル: NUHR.Fの 純負債対資本比率 を計算して 満足できる ものであるかどうかを判断するにはデータが不十分です。負債の削減: NUHR.Fの負債対資本比率が過去 5 年間で減少したかどうかを判断するにはデータが不十分です。債務返済能力: NUHR.Fの負債が 営業キャッシュフロー によって 十分にカバーされている かどうかを判断するにはデータが不十分です。インタレストカバレッジ: NUHR.Fの負債に対する 利息支払い が EBIT によって 十分にカバーされている かどうかを判断するにはデータが不十分です。貸借対照表健全な企業の発掘7D1Y7D1Y7D1YTech 業界の健全な企業。View Dividend企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2025/11/01 23:32終値2025/08/04 00:00収益2023/06/30年間収益2023/06/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Nuheara Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Apr 10Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 1.850332 million.Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 1.850332 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 30,838,873 Price\Range: AUD 0.06 Security Features: Attached Options Transaction Features: Subsequent Direct Listing
お知らせ • Nov 22Nuheara Limited Announces the Retirement of David Cannington as Non-Executive DirectorNuheara Limited announced that Non-executive Director and co-founder Mr. David Cannington has announced his decision to retire from the Nuheara Board of Directors. As a co-founder of the company and having previously stepped down from executive duties in March 2022, David now concludes his service on the Board.
お知らせ • Nov 09Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 3.929624 million.Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 3.929624 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 3,846,154 Price\Range: AUD 0.13 Discount Per Security: AUD 0.0039 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 19,458,649 Price\Range: AUD 0.13 Discount Per Security: AUD 0.0039 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 6,923,077 Price\Range: AUD 0.13 Discount Per Security: AUD 0.0039 Transaction Features: Rights Offering
お知らせ • Sep 15Nuheara Limited, Annual General Meeting, Nov 22, 2023Nuheara Limited, Annual General Meeting, Nov 22, 2023, at 09:00 W. Australia Standard Time. Location: Anzac Club, 28 St Georges Terrace, Perth WA Australia
お知らせ • Jul 18Nuheara Limited Announces Appointment of Catherine Morgan as Head of Compliance, Regulatory and LegalNuheara Limited announced the key Executive appointment of Catherine Morgan as the Head of Compliance, Regulatory and Legal. This appointment completes Nuheara's global restructure announced 28 April 2023 and cements the Company's transformation over the past two years into a medical device manufacturer of world-first US FDA- cleared Over The Counter (OTC) Hearing Aids. Catherine joins the Nuheara C-suite with over +20 years of experience in the hearing industry, bringing a deep understanding of the hearing healthcare, medical device industry, global regulatory requirements, and quality standards. In this new role Catherine will be responsible for driving regulatory strategies, ensuring adherence to global regulations and standards, and driving continuous improvement initiatives within quality management systems. They will collaborate closely with cross-functional teams to streamline regulatory submissions, enhance product quality, and foster a culture of continuous improvement in all aspects of regulatory and quality operations. Prior to joining Nuheara, Catherine held senior leadership positions at the National Acoustic Laboratories and more than 14 years with Cochlear Ltd. Catherine has a proven track record of successfully navigating complex regulatory landscapes and implementing strong clinical quality management processes and while fostering a culture of regulatory compliance and quality excellence within the hearing market.
お知らせ • Jun 07Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 4.4 million.Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 4.4 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 24,275,862 Price\Range: AUD 0.145 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 6,068,966 Price\Range: AUD 0.145 Transaction Features: Subsequent Direct Listing
お知らせ • Jan 04Nuheara Announces Commercial Availability of HP Hearing PRO OTC Hearing AidNuheara announced the commercial availability of its HP Hearing PRO. Consumers can now pre-order the HP Hearing PRO self-fitting, air-conduction, OTC hearing soon be able to purchase the product from any retailer carrying the product including Best Buy and Crutchfield. Nuheara's HP Hearing PRO is the first product cleared through the FDA's 510(k) process for both 874.3325 self-fitting and the 800.30 OTC hearing aid classifications under a new product classification code "QUH". HP Hearing PRO is the first FDA cleared self-fitting OTC hearing aid with Hybrid Active Noise Cancellation. The innovative Ear ID(TM) software-in-medical-device and earbud form factor sets the HP Hearing PRO apart from other devices on the market . The HP Hearing PRO self-fitting OTC hearing aids look nothing like a traditional hearing aid. The HP Hearing PRO self- fitting OTC hearing aid brings together superb medical-grade hearing aid technology with the highly desired features of wireless earbuds into a multifunctional device. Users can enjoy clinically-proven natural sound quality. The HP Hearing PRO provides a lifestyle-friendly hearing aid experience with support for situational use and clinically-proven 30% improved hearing using the Focus directionality feature, adjusted to the user's preferences with a tap of the HP Hearing app. Orders can now be placed from retailers and ecommerce partners throughout the US. The recommended retail price for a pair of HP Hearing PRO hearing aids along with an on-the-go charging case is USD 699.00. Product is expected to ship to customers before the end of calendar Quarter 1, 2023. Built to medical-device standards and meeting all FDA requirements for safety and efficacy, the HP Hearing PRO features Ear ID(TM) self-fitting software and technology powered by Nuheara. The HP Hearing PRO self-fitting OTC hearing aid has been clinically proven to be substantially equivalent to a professionally fit hearing aid. The proprietary Ear ID software tests the wearer's individual hearing thresholds from low frequency to high frequency in each ear, then automatically programs the HP Hearing PRO hearing aids for each ear. This ability for the consumer to self-fit through the HP Hearing application, for iOS and Android platform mobile devices, allows a quick and easy acclimation experience for the consumer. The entire experience takes about 10-15 minutes from unboxing through customization of the user's personalized profile to accommodate their perceived mild-to-moderate hearing loss. In addition to the HP Hearing PRO's capabilities as an OTC hearing aid, this innovative product streams media and phone calls via Bluetooth(R). The Active Noise Cancellation minimizes background noise for an immersive sound experience during phone calls or when streaming music. Additional features include: Hearing app for iOS and Android; Rechargeable built-in Li-ion batteries; Medical-grade USB-C charge case; Battery life is up to 8 hours hearing aid processing per full charge per hearing aid; Clinically-proven natural sound quality. Most importantly, the HP Hearing PRO has been clinically validated through research cometed by the National Acoustic c Laboratories to provide a 30% speech understanding improvement in the presence of noise using the directional microphone feature called Focus. This is a huge benefit for consumers in restaurants or social situations where background noise makes understanding speech difficult. Now, at the touch of the HP Hearing app, a wearer can switch the directional microphone settings to Focus on sounds towards their front, quickly allowing for immediate improvement in speech understanding.